Back to results
US 12,016,886 B2Granted
Microvascular endothelial cell comprising a nucleic acid encoding an anti-TDP-43 fab
AssigneeALSaTECH, Inc.
InventorsClaude Nicolau, Claudine Kieda, Reynald Thinard, Ruth Greferath, Melanie Chevalier
Life of this patent
Estimating the term…
Abstract
The present invention relates, in part, to cell-based gene therapies, including those targeting, by way of non-limiting example, TDP43 and Aβ aggregates, for the use in neurodegenerative disorders, including without limitation Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease, respectively.
Claims10
A composition comprising a nucleic acid encoding a Fab directed against TDP43, the anti-TDP43 Fab comprising:
- (i) a variable heavy domain (VH) comprising:
- the amino acid sequence of SEQ ID NO:
- 13 and complementarity-determining region (CDR) 1 having the amino acid sequence of SEQ ID NO:
- 19,
- CDR2 having the amino acid sequence of SEQ ID NO:
- 20, and
- CDR3 having the amino acid sequence of SEQ ID NO:
- 21;
- and
- (ii) a variable light domain (VL) comprising:
- the amino acid sequence of SEQ ID NO:
- 14 and
- CDR1 having the amino acid sequence of SEQ ID NO:
- 22,
- CDR2 having the amino acid sequence of SEQ ID NO:
- 23, and
- CDR3 having the amino acid sequence of SEQ ID NO:
- 24.
15 more elements
An isolated microvascular endothelial cell (MEC) comprising a nucleic acid encoding a Fab directed against TDP43, the anti-TDP-43 Fab comprising:
- (i) a variable heavy domain (VH) comprising:
- the amino acid sequence of SEQ ID NO:13 and complementarity-determining region (CDR) 1 having the amino acid sequence of SEQ ID NO:19, CDR2 having the amino acid sequence of SEQ ID NO:20, and CDR3 having the amino acid sequence of SEQ ID NO:21;
- and
- (ii) a variable light domain (VL) comprising:
- the amino acid sequence of SEQ ID NO:14 and CDR1 having the amino acid sequence of SEQ ID NO:22, CDR2 having the amino acid sequence of SEQ ID NO:23, and CDR3 having the amino acid sequence of SEQ ID NO:24.
2 more elements
Dependencies are inferred from the claim text.